Cytotoxic drugs drug screening assays antitumor. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy22

T-Lymphocytes, Cytotoxic Cell Line, Tumor Tumor Cells, Cultured Cell Line Killer Cells, Natural CD8-Positive T-Lymphocytes Cells, Cultured T-Lymphocytes Clone Cells HT29 Cells Dendritic Cells Spleen Lymphocytes, Tumor-Infiltrating HL-60 Cells HCT116 Cells Bone Marrow CD4-Positive T-Lymphocytes Jurkat Cells Lymphocytes K562 Cells T-Lymphocytes, Regulatory Bone Marrow Cells

Organisms12

Mice, Nude Mice, Inbred BALB C Mice, Inbred C57BL Mice, SCID Mice, Inbred Strains Adenoviridae Mice, Inbred DBA Mice, Inbred C3H Oncolytic Viruses Cricetinae Mice, Transgenic Streptomyces

Diseases38

Neoplasms, Experimental Neoplasms Leukemia P388 Melanoma, Experimental Sarcoma 180 Colonic Neoplasms Lung Neoplasms Melanoma Leukemia L1210 Breast Neoplasms Lymphoma Ovarian Neoplasms Mammary Neoplasms, Experimental Neuroblastoma Sarcoma, Experimental Neovascularization, Pathologic Fibrosarcoma Adenocarcinoma Carcinoma, Lewis Lung Glioma Vomiting Neoplasm Metastasis Leukemia Prostatic Neoplasms Disease Models, Animal Brain Neoplasms Burkitt Lymphoma Liver Neoplasms Pancreatic Neoplasms Multiple Myeloma Leukemia, Lymphocytic, Chronic, B-Cell Mast-Cell Sarcoma Leukemia, Experimental Carcinoma Carcinoma, Ehrlich Tumor Colorectal Neoplasms Carcinoma, Non-Small-Cell Lung Nausea

Chemicals and Drugs112

Antineoplastic Agents Doxorubicin Antibiotics, Antineoplastic Cytostatic Agents Cytotoxins Antineoplastic Agents, Phytogenic Cisplatin P-Glycoprotein Prodrugs Pore Forming Cytotoxic Proteins Daunorubicin Antibodies, Monoclonal Cyclophosphamide Nitrogen Mustard Compounds Vinblastine Chlorambucil Vincristine Fluorouracil Cancer Vaccines Etoposide Immunotoxins Maytansine Lomustine Paclitaxel Antineoplastic Agents, Alkylating Methotrexate Antimetabolites, Antineoplastic Antigens, Neoplasm Membrane Glycoproteins Melphalan Caspases Mechlorethamine Drug Carriers Angiogenesis Inhibitors Aclarubicin Neoplasm Proteins Perforin Proto-Oncogene Proteins c-bcl-2 Interferon-gamma Camptothecin Organoplatinum Compounds Enzyme Inhibitors Granzymes Enediynes Deoxycytidine Interleukin-2 beta-Aminoethyl Isothiourea Floxuridine Misonidazole Thioguanine Indoles Quinazolines Taxoids Caspase 3 Recombinant Proteins Multidrug Resistance-Associated Proteins Antigens, CD95 Verapamil Cytarabine Antibodies, Monoclonal, Humanized bcl-X Protein Mitoxantrone HLA-A2 Antigen RNA, Messenger Dacarbazine DNA, Neoplasm Epitopes, T-Lymphocyte Tumor Suppressor Protein p53 Tumor Necrosis Factor-alpha Cyclosporins Caspase 9 Liposomes Triazines Oligopeptides Protein Kinase Inhibitors Plant Extracts Dactinomycin Caspase 8 DNA Receptor, Epidermal Growth Factor Recombinant Fusion Proteins Epitopes ATP-Binding Cassette Transporters Apoptosis Regulatory Proteins Pyrimidines Caspase Inhibitors TNF-Related Apoptosis-Inducing Ligand Ellipticines HLA-A Antigens H-2 Antigens Interleukin-12 Antigens, CD DNA Topoisomerases, Type II Busulfan Antigens, CD8 6-Mercaptopurine Oligonucleotides, Antisense Histocompatibility Antigens Class I Piperazines CTLA-4 Antigen Benzamides Carboplatin Intercalating Agents Adjuvants, Immunologic Glutathione Colchicine Immunoconjugates Antibodies, Neoplasm Bleomycin Immunosuppressive Agents bcl-2-Associated X Protein Topoisomerase I Inhibitors

Analytical, Diagnostic and Therapeutic Techniques and Equipment39

Drug Screening Assays, Antitumor Xenograft Model Antitumor Assays Neoplasms, Experimental Neoplasm Transplantation Inhibitory Concentration 50 Transplantation, Heterologous Melanoma, Experimental Gloves, Protective Antineoplastic Combined Chemotherapy Protocols Immunotherapy Flow Cytometry Cytotoxicity Tests, Immunologic Immunotherapy, Adoptive Drug Delivery Systems Lymphocyte Activation Drug Carriers Tumor Stem Cell Assay Drug Evaluation, Preclinical Combined Modality Therapy Drug Packaging Mammary Neoplasms, Experimental Drug Administration Schedule Sarcoma, Experimental Transfection Blotting, Western Genetic Therapy Injections, Intralesional Oncolytic Virotherapy Treatment Outcome Drug Therapy, Combination Tumor Burden Disease Models, Animal Drug Design Immunohistochemistry Clinical Trials as Topic Reverse Transcriptase Polymerase Chain Reaction Leukemia, Experimental Infusions, Intravenous Colony-Forming Units Assay

Phenomena and Processes34

Cell Survival Cytotoxicity, Immunologic Apoptosis Drug Synergism Drug Resistance, Neoplasm Dose-Response Relationship, Drug Drug Resistance Drug Resistance, Multiple Inhibitory Concentration 50 Cell Proliferation Cell Division Time Factors Cell Death Cell Cycle Lymphocyte Activation Signal Transduction DNA Damage Transfection Gene Expression Regulation, Neoplastic Molecular Structure Immunity, Cellular Genetic Vectors Antibody-Dependent Cell Cytotoxicity Down-Regulation Drug Interactions Structure-Activity Relationship Kinetics Mutation Gene Expression Base Sequence Amino Acid Sequence Tumor Escape Phosphorylation Enzyme Activation

Disciplines and Occupations2

Drug Design Immunohistochemistry

Technology, Industry, Agriculture3

Gloves, Protective Drug Packaging Liposomes

Information Science3

Molecular Sequence Data Base Sequence Amino Acid Sequence

Health Care5

Oncology Service, Hospital Equipment Contamination Pharmacy Service, Hospital Treatment Outcome Clinical Trials as Topic

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Technology, Industry, Agriculture Information Science Health Care

Antineoplastic Agents T-Lymphocytes, Cytotoxic Drug Screening Assays, Antitumor Xenograft Model Antitumor Assays Cell Line, Tumor Tumor Cells, Cultured Doxorubicin Antibiotics, Antineoplastic Cytostatic Agents Cell Survival Cytotoxicity, Immunologic Apoptosis Cytotoxins Mice, Nude Neoplasms, Experimental Neoplasms Neoplasm Transplantation Drug Synergism Drug Resistance, Neoplasm Dose-Response Relationship, Drug Antineoplastic Agents, Phytogenic Mice, Inbred BALB C Cisplatin Leukemia P388 Drug Resistance P-Glycoprotein Drug Resistance, Multiple Prodrugs Pore Forming Cytotoxic Proteins Daunorubicin Antibodies, Monoclonal Mice, Inbred C57BL Inhibitory Concentration 50 Transplantation, Heterologous Cyclophosphamide Nitrogen Mustard Compounds Cell Proliferation Melanoma, Experimental Gloves, Protective Sarcoma 180 Vinblastine Cell Division Chlorambucil Vincristine Fluorouracil Cancer Vaccines Etoposide Immunotoxins Antineoplastic Combined Chemotherapy Protocols Immunotherapy Maytansine Lomustine Mice, SCID Flow Cytometry Cytotoxicity Tests, Immunologic Cell Line Colonic Neoplasms Lung Neoplasms Melanoma Leukemia L1210 Paclitaxel Antineoplastic Agents, Alkylating Killer Cells, Natural CD8-Positive T-Lymphocytes Immunotherapy, Adoptive Methotrexate Antimetabolites, Antineoplastic Time Factors Oncology Service, Hospital Antigens, Neoplasm Cell Death Membrane Glycoproteins Breast Neoplasms Melphalan Caspases Cells, Cultured Cell Cycle Drug Delivery Systems Lymphocyte Activation Mechlorethamine Drug Carriers T-Lymphocytes Angiogenesis Inhibitors Tumor Stem Cell Assay Aclarubicin Clone Cells Neoplasm Proteins Lymphoma Drug Evaluation, Preclinical Ovarian Neoplasms Perforin HT29 Cells Proto-Oncogene Proteins c-bcl-2 Combined Modality Therapy Drug Packaging Interferon-gamma Signal Transduction Camptothecin Mammary Neoplasms, Experimental Drug Administration Schedule

No FAQ available that match "cytotoxic drugs drug screening assays antitumor"